Drug-eluting coronary-artery stents

GG Stefanini, DR Holmes Jr - New England Journal of Medicine, 2013 - Mass Medical Soc
Drug-Eluting Coronary-Artery Stents | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside

J Nicolas, CA Pivato, M Chiarito… - Cardiovascular …, 2023 - academic.oup.com
Coronary stents have revolutionized the treatment of coronary artery disease. Compared
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …

Randomized trial of stents versus bypass surgery for left main coronary artery disease

SJ Park, YH Kim, DW Park, SC Yun… - … England Journal of …, 2011 - Mass Medical Soc
Background Percutaneous coronary intervention (PCI) is increasingly used to treat
unprotected left main coronary artery stenosis, although coronary-artery bypass grafting …

Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from …

S Bangalore, S Kumar, M Fusaro, N Amoroso… - Circulation, 2012 - Am Heart Assoc
Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade;
however, the relative short-and long-term efficacy and safety of DES compared with bare …

Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study

JM Ahn, JH Roh, YH Kim, DW Park, SC Yun… - Journal of the American …, 2015 - jacc.org
Background: In a previous randomized trial, we found that percutaneous coronary
intervention (PCI) was not inferior to coronary artery bypass grafting (CABG) for the …

Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation'drug-eluting stents: a report from the nationwide Swedish Coronary …

G Sarno, B Lagerqvist, O Fröbert, J Nilsson… - European heart …, 2012 - academic.oup.com
Aims To compare the long-term outcome after percutaneous coronary intervention with 'new-
generation'drug-eluting stents (n-DES) to 'older generation'DES (o-DES), and bare-metal …

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease …

GG Stefanini, B Kalesan, PW Serruys, D Heg… - The Lancet, 2011 - thelancet.com
Background The effectiveness of durable polymer drug-eluting stents comes at the expense
of delayed arterial healing and subsequent late adverse events such as stent thrombosis …

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice …

EP Navarese, K Tandjung, B Claessen, F Andreotti… - Bmj, 2013 - bmj.com
Objectives To investigate the safety and efficacy of durable polymer drug eluting stents
(DES) and biodegradable polymer biolimus eluting stents (biolimus-ES). Design Network …

Two-year outcomes after first-or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention …

M Valgimigli, M Tebaldi, M Borghesi, P Vranckx… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: This study sought to assess device-specific outcomes after implantation of bare-
metal stents (BMS), zotarolimus-eluting Endeavor Sprint stents (ZES-S), paclitaxel-eluting …

Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention

DW Park, YH Kim, SC Yun, JM Ahn, JY Lee… - European heart …, 2013 - academic.oup.com
Aims Peri-procedural myocardial infarction (MI) is a not infrequent complication of
percutaneous coronary intervention (PCI), but conflicting information exists regarding …